Determination of serum interleukin-13 and nerve growth factor in patients with systemic lupus erythematosus and clinical significance

Abstract

The changes in the levels of serum interleukin-13 (IL-13) and nerve growth factor (NGF) in patients with systemic lupus erythematosus (SLE) and their clinical significance were investigated. Sandwich ELISA was used to determine the levels of serum IL-13 and NGF in 35 SLE patients and 15 normal controls. The results showed that the levels of serum IL-13 (92.69±9.87 pg/ml) and NGF (339.69±25.60 pg/ml) in active SLE patients were significantly higher than those in inactive SLE patients (IL-13, 54.22±9.31 pg/ml; NGF, 300.89±33.51 pg/ml) (P<0. 01). The inactive patients also had significantly increased serum levels of IL-13 and NGF as compared with normal controls (IL-13, 35.20±12.70 pg/ml; NGF, 111.40±32.54 pg/ml;P<0.05 andP<0.01, respectively). Spearman correlation analysis revealed that the serum IL-13 levels were correlated with disease activity index of SLE (SLEDAI), ESR and serum levels of C₃ (r=0. 813, 0.504, −0.605, respectively). The serum NGF levels were also correlated with above markers (r=0.442, 0.338, −0.463, respectively). The serum levels of IL-13 and NGF had a positive correlation (r=0.506,P<0.01). It was suggested that IL-13 and NGF might be involved in the pathogenesis of SLE and closely correlated with disease activity.

Keywords

lupus erythematosus / systemic / interleukin-13 / nerve growth factor

References

[1] BombardierC, GladmanD D, UrowitzM B, et al.. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on prognosis studies in SLE. Arthritis Rheum, 1992, 35(6): 630-630

[2] LiuA H. Allergy and asthma: classic TH2 diseases. Allergy Asthma Proc, 2000, 21(4): 227-227

[3] GongJ Q, ChenZ Q, HuZ J, et al.. Expression of IL-13 mRNA in the peripheral blood mononuclear cells of the patients with systemic lupus erythematosus. J Clin Dermato (Chinese), 2001, 30(5): 287-287

[4] AloeL, Bracci-LaudieroL, BoniniS, et al.. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy, 1997, 52(9): 883-883

[5] BoniniS, RasiG, Bracci-LaudieroM L, et al.. Nerve growth factor: neurotrophin or cytokine?. Int Arch Allergy Immunol, 2003, 131(2): 80-80

[6] LambiaseA, Bracci-LaudieroL, BoniniS, et al.. Human CD4+T-cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol, 1997, 100(3): 408-408

[7] KimataH, YoshidaA, IshiokaC, et al.. Stimulation of Ig production and growth of human lymphoblastoid B-cell lines by nerve growth factor. Immunology, 1991, 72(3): 451-451

[8] BrodieC, OshibaA, RenzH, et al.. Nerve growth-factor and anti-CD40 provide opposite signals for the production of IgE in interleukin-4-treated lymphocytes. Eur J Immunol, 1996, 26(1): 171-171

[9] SinA Z, RocheE M, TogiasA, et al.. Nerve growth factor or IL-3 induces more IL-13 production from basophils of allergic subjects than from basophils of non-allergic subjects. J Allergy Clin Immunol, 2001, 108(3): 387-387

[10] BraunA, AppelE, BaruchR, et al.. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol, 1998, 28(10): 3240-3240